About Us

SingHealth Investigational Medicine Unit (IMU) is a dedicated early phase clinical research unit, which supports the research of commercial partners and independent investigators.

SingHealth IMU provides services to facilitate: 

  • Proof of concept, first-in-man or early stage of clinical development of investigational drugs, vaccines and devices
  • Identification and validation of novel disease biomarkers
  • Pharmacokinetics and pharmacodynamics studies
  • Healthy volunteer trials, supported by a robust database

SingHealth IMU is located at the heart of Singapore's largest medical campus. Tapping into the high patient volume and wide range of medical expertise on the campus, SingHealth IMU is able to conduct clinical trials across the medical spectrum.

Part of an academic campus, SingHealth IMU also promotes medical research practice and methodology to train doctors, pharmacists, nurses and coordinators in clinical trial management.

Committed to Quality Research

SingHealth IMU is dedicated to conducting early phase clinical research. Its projects are supported by a team of dedicated staff comprising of clinical research coordinators and clinical research nurses, trained in ICH-GCP. SingHealth IMU specializes in disease that impacts patients in Asia, including in:


  • Oncology
  • Haematology
  • Cardiology
  • Gastroenterology
  • Infectious Disease
  • Endocrinology


Defining Tomorrow’s Medicine: Through the conduct of early phase clinical research


Care to Heal: Translating innovations into improved patient care

Educate to Empower:
Educating and training the next generation of researchers in early phase clinical trial research ethics and methodology

Innovate to Advance: Developing thought leadership through research innovations